[go: up one dir, main page]

SE9000595D0 - NEW PEPTIDES, DIAGNOSTIC ANTIGENS AND AN IMMUNOASSAY METHOD - Google Patents

NEW PEPTIDES, DIAGNOSTIC ANTIGENS AND AN IMMUNOASSAY METHOD

Info

Publication number
SE9000595D0
SE9000595D0 SE9000595A SE9000595A SE9000595D0 SE 9000595 D0 SE9000595 D0 SE 9000595D0 SE 9000595 A SE9000595 A SE 9000595A SE 9000595 A SE9000595 A SE 9000595A SE 9000595 D0 SE9000595 D0 SE 9000595D0
Authority
SE
Sweden
Prior art keywords
antigen
immunoassay method
peptides
new peptides
diagnostic
Prior art date
Application number
SE9000595A
Other languages
Swedish (sv)
Other versions
SE9000595L (en
SE468168B (en
Inventor
J Blomberg
Original Assignee
Replico Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Replico Ab filed Critical Replico Ab
Priority to SE9000595A priority Critical patent/SE468168B/en
Publication of SE9000595D0 publication Critical patent/SE9000595D0/en
Priority to PCT/SE1991/000114 priority patent/WO1991013360A1/en
Priority to AU74448/91A priority patent/AU7444891A/en
Publication of SE9000595L publication Critical patent/SE9000595L/en
Publication of SE468168B publication Critical patent/SE468168B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • AIDS & HIV (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Peptides or antigenic parts thereof and a diagnostic antigen are described, which antigen has the ability of binding to antibodies which have a binding affinity for compounds containing an amino acid sequence corresponding to an epitope or clusters of epitopes of HIV-1 p24, wherein it mainly consists of said antigen, which is selected from said peptides or antigenic parts thereof. Further, a method of discriminating between a false and true diagnosed HIV-positive serum sample from a subject using an immunoassay, wherein said diagnostic antigen is used, is described.
SE9000595A 1990-02-20 1990-02-20 HIV-1, P24 PEPTIDES, DIAGNOSTIC ANTIGENS AND PROCEDURES FOR DIFFERENTIAL DIAGNOSTICS OF PRELIMINARY HIV-1 POSITIVE SERUM TESTS SE468168B (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE9000595A SE468168B (en) 1990-02-20 1990-02-20 HIV-1, P24 PEPTIDES, DIAGNOSTIC ANTIGENS AND PROCEDURES FOR DIFFERENTIAL DIAGNOSTICS OF PRELIMINARY HIV-1 POSITIVE SERUM TESTS
PCT/SE1991/000114 WO1991013360A1 (en) 1990-02-20 1991-02-18 NEW HIV p24 PEPTIDES, DIAGNOSTIC ANTIGENS AND DISCRIMINATIVE IMMUNOASSAY METHOD
AU74448/91A AU7444891A (en) 1990-02-20 1991-02-18 New hiv p24 peptides, diagnostic antigens and discriminative immunoassay method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9000595A SE468168B (en) 1990-02-20 1990-02-20 HIV-1, P24 PEPTIDES, DIAGNOSTIC ANTIGENS AND PROCEDURES FOR DIFFERENTIAL DIAGNOSTICS OF PRELIMINARY HIV-1 POSITIVE SERUM TESTS

Publications (3)

Publication Number Publication Date
SE9000595D0 true SE9000595D0 (en) 1990-02-20
SE9000595L SE9000595L (en) 1991-08-21
SE468168B SE468168B (en) 1992-11-16

Family

ID=20378616

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9000595A SE468168B (en) 1990-02-20 1990-02-20 HIV-1, P24 PEPTIDES, DIAGNOSTIC ANTIGENS AND PROCEDURES FOR DIFFERENTIAL DIAGNOSTICS OF PRELIMINARY HIV-1 POSITIVE SERUM TESTS

Country Status (3)

Country Link
AU (1) AU7444891A (en)
SE (1) SE468168B (en)
WO (1) WO1991013360A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4039925A1 (en) * 1990-12-14 1992-06-17 Behringwerke Ag SELECTED PEPTIDES OF THE GROUP-SPECIFIC ANTIGEN (GAG) OF HUMANEM IMMUNE DEFICIENCY VIRUS (HIV), THEIR PRODUCTION AND USE
SE9101863D0 (en) * 1991-06-13 1991-06-13 Replico Medical Ab PEPTIDES, DIAGNOSTIC ANTIGEN, VACCINE COMPOSITION AND PROCEDURES FOR SELECTING HIV STARMS
AU2221600A (en) 1998-12-31 2000-07-31 Chiron Corporation Improved expression of hiv polypeptides and production of virus-like particles
AU2487300A (en) 1998-12-31 2000-07-31 Chiron Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
ES2299276T3 (en) 1998-12-31 2008-05-16 Novartis Vaccines And Diagnostics, Inc. MODIFIED HIV ENV POLIPEPTIDES.
NO311807B1 (en) 1999-03-04 2002-01-28 Bionor Immuno As HIV peptides, antigens, vaccine preparations, immunoassay test kits and a method for detecting antibodies induced by HIV
MXPA02007478A (en) * 2000-02-04 2004-08-23 Univ Duke Human immunodeficiency virus vaccine.
NO314588B1 (en) 2000-09-04 2003-04-14 Bionor Immuno As HIV peptides, antigens, vaccine composition, immunoassay test kits and a method for detecting antibodies induced by HIV
US7211659B2 (en) 2001-07-05 2007-05-01 Chiron Corporation Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof
US20030170614A1 (en) 2001-08-31 2003-09-11 Megede Jan Zur Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof
EP3967323A3 (en) 2012-06-06 2022-05-04 Bionor Immuno AS Hiv vaccine
EP3166633A1 (en) 2014-07-11 2017-05-17 Bionor Immuno AS Method for reducing and/or delaying pathological effects of human immunodeficiency virus i (hiv) or for reducing the risk of developing acquired immunodeficiency syndrome (aids)
WO2016177833A1 (en) 2015-05-04 2016-11-10 Bionor Immuno As Dosage regimen for hiv vaccine

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986002383A1 (en) * 1984-10-18 1986-04-24 Institut Pasteur Envelope antigens of lymphadenopathy associated virus and their applications
CA1341384C (en) * 1985-04-08 2002-08-20 Susan Mitsue Watanabe Expression and diagnostic use of gag encoded peptides which are immunologically reactive with antibodies to lav
DE3650175T3 (en) * 1985-04-29 2007-09-06 Bio-Rad Laboratories, Inc., Hercules SYNTHETIC ANTIGENIC TO IDENTIFY AIDS.
US4808536A (en) * 1986-02-27 1989-02-28 Centocor, Inc. Immunochemical method for detection of antibody against HTLV-III core protein based upon recombinant HTLV-III gag gene encoded protein
NZ221440A (en) * 1986-08-20 1991-11-26 Genetic Systems Corp Composition containing monoclonal antibodies/peptides useful in treating and diagnosing hiv infections
CA1339363C (en) * 1987-05-01 1997-08-26 Alan Ray Flesher Monoclonal antibodies to specific antigenic regions of the human immunodeficiency virus and methods for use
EP0330359A3 (en) * 1988-02-25 1991-06-05 Bio-Rad Laboratories, Inc. Composition useful in the diagnosis and treating of hiv-1 infection
JP2994031B2 (en) * 1988-12-20 1999-12-27 クラリティ テクノロジーズ インコーポレイテッド Method for determining the presence or amount of HIV-1 or HIV-2 antibody, immunospecific reagent, synthetic peptide, diagnostic kit, method for preparing HIV-1 or HIV-2 antibody, immunogen and antibody

Also Published As

Publication number Publication date
SE9000595L (en) 1991-08-21
SE468168B (en) 1992-11-16
AU7444891A (en) 1991-09-18
WO1991013360A1 (en) 1991-09-05

Similar Documents

Publication Publication Date Title
Towbin et al. Immunoblotting in the clinical laboratory
NZ219113A (en) Hiv peptide containing epitope of the env protein
SE8704185L (en) NEW PEPTIDES, ARTIFICIAL ANTIGENS AND IMMUNO ANALYSIS TEST RATES
SE9000595D0 (en) NEW PEPTIDES, DIAGNOSTIC ANTIGENS AND AN IMMUNOASSAY METHOD
ES2171414T3 (en) IMMUNO TESTS FOR ANTI-HCV ANTIBODIES USING ANTIGENS WITH CONFORMATIONAL EPITHOPES.
DE3265768D1 (en) A method and a kit for the assay of antibodies to soluble antigens
RU2004136165A (en) METHOD FOR SIMULTANEOUS DETECTION OF ANTIGENS AND ANTIBODIES AGAINST INFECTIOUS MICROORGANISM
ATE128738T1 (en) METHOD FOR THE RAPID AND SENSITIVE DETECTION OF IGM ANTIBODIES AGAINST RETROVIRAL ANTIGENS.
US6686169B2 (en) Reagent for the detection of Staphylococcus aureus by agglutination
ES520012A0 (en) AGGLUTINATION PROCEDURE WITH LATEX FOR THE DETECTION OR DETERMINATION OF A PARTICIPANT IN AN IMMUNOLOGICAL REACTION.
KR880014376A (en) Monoclonal Antibodies of the HIV Specific Antigen Region and Their Uses
McArthur et al. A rapid micro-method for screening eel sera for antibodies against the digenean Telogaster opisthorchis Macfarlane, 1945.
SE9101863D0 (en) PEPTIDES, DIAGNOSTIC ANTIGEN, VACCINE COMPOSITION AND PROCEDURES FOR SELECTING HIV STARMS
RU2137138C1 (en) Diagnostic composition for identification of syphilis and test-system "akvasif" on its base
EP0951646B1 (en) THE IMMUNOENZIMATIC ASSAY FOR THE DIAGNOSIS OF EQUINE INFECTIOUS ANEMIA VIRUS DISEASE BY USING RECOMBINANT PROTEIN (rGP90) DERIVED FROM EQUINE INFECTIOUS ANEMIA VIRUS
SE8903985D0 (en) NEW PEPTIDES, DIAGNOSTIC ANTIGENS AND AN IMMUNOASSAY
JPH05507559A (en) Immunoassay for anti-HIV-1 antibodies
ATE281471T1 (en) ANTIBODIES TEST KIT FOR DETERMINING AMYLIN
Schmeer Answer to the commentary of Dr. Heyermann
JPS6490197A (en) Peptide
Portetelle et al. Competition enzyme-linked immunosorbent assay(ELISA) for the diagnosis of bovine leukemia virus infection.
ES2075803A1 (en) Procedure for detecting pneumolysin.

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 9000595-0

Format of ref document f/p: F